1. FDA clears narrow use of Lynparza in early prostate cancer — AstraZeneca drops Skyrizi rival after seeing R&D timeline spiral --FDA approves Pfizer’s RSV vaccine for older adults -- See more on our front page news http://bit.ly/w28kSd See more on our front page news
    Dismiss Notice

Qui tam relator question

Discussion in 'Ask a Whistleblower Attorney' started by anonymous, Jan 14, 2021 at 2:21 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    I have heard that when a whistleblower lawsuit is filed only the 1st person to file is rewarded (the 2nd and 3rd just have their names outed but receive no benefit).

    Is this true?

  2. anonymous

    anonymous Guest